These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12544424)

  • 1. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes.
    Aronson D
    J Hypertens; 2003 Jan; 21(1):3-12. PubMed ID: 12544424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of arterial stiffening: role of glycation - a mini-review.
    Sell DR; Monnier VM
    Gerontology; 2012; 58(3):227-37. PubMed ID: 22222677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein glycation, diabetes, and aging.
    Ulrich P; Cerami A
    Recent Prog Horm Res; 2001; 56():1-21. PubMed ID: 11237208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological prevention of cardiovascular aging--targeting the Maillard reaction.
    Aronson D
    Br J Pharmacol; 2004 Aug; 142(7):1055-8. PubMed ID: 15237100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.
    Brownlee M; Vlassara H; Kooney A; Ulrich P; Cerami A
    Science; 1986 Jun; 232(4758):1629-32. PubMed ID: 3487117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat.
    Sell DR; Nelson JF; Monnier VM
    J Gerontol A Biol Sci Med Sci; 2001 Sep; 56(9):B405-11. PubMed ID: 11524442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
    Vasan S; Foiles P; Founds H
    Arch Biochem Biophys; 2003 Nov; 419(1):89-96. PubMed ID: 14568012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats.
    Yang S; Litchfield JE; Baynes JW
    Arch Biochem Biophys; 2003 Apr; 412(1):42-6. PubMed ID: 12646266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):97-101. PubMed ID: 15032654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-product cross-linking inhibits biomechanical plasticity and characteristic failure morphology of native tendon.
    Lee JM; Veres SP
    J Appl Physiol (1985); 2019 Apr; 126(4):832-841. PubMed ID: 30653412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosslink breakers: a new approach to cardiovascular therapy.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Opin Cardiol; 2004 Jul; 19(4):336-40. PubMed ID: 15218393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
    Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
    Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease.
    Zieman S; Kass D
    Congest Heart Fail; 2004; 10(3):144-9; quiz 150-1. PubMed ID: 15184729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats.
    Sajithlal GB; Chithra P; Chandrakasan G
    Biochem Pharmacol; 1998 Dec; 56(12):1607-14. PubMed ID: 9973181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
    Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
    Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.
    Norton GR; Candy G; Woodiwiss AJ
    Circulation; 1996 May; 93(10):1905-12. PubMed ID: 8635270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes.
    Paul RG; Bailey AJ
    Int J Biochem Cell Biol; 1996 Dec; 28(12):1297-310. PubMed ID: 9022289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonenzymatic glycation of collagen in aging and diabetes.
    Reiser KM
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):17-29. PubMed ID: 1984239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy.
    Herrmann KL; McCulloch AD; Omens JH
    Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1277-84. PubMed ID: 12595292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.